[1] DELHORME J B, HONORE C, BENHAIM L, et al. Long-term survival after aggressive treatment of relapsed serosal or distant pseudomyxoma peritonei[J]. Eur J Surg Oncol, 2017, 43(1):159-167. [2] 王慧琴, 李明, 孙露, 等. 绝经后伴腹膜假性黏液瘤的原发性阑尾黏液腺癌5例临床特征分析[J]. 中国妇幼保健, 2017, 32(6):1173-1174. [3] 马越, 涂水平. 原发性阑尾黏液性肿瘤的临床特点和生存分析[J]. 胃肠病学, 2016, 21(11):662-667. [4] CARR N J, FINCN J, ILESLEY I C, et al. Pathology and prognosis in pseudomyxoma peritonei: a review of 274 cases[J]. J Clin Pathol, 2012, 65(10):919-923. [5] 王延海, 武云昊, 蔡爱露, 等. 阑尾来源腹膜假性黏液瘤临床及超声特点分析[J]. 中国医学工程, 2011, 19(8):57-58, 60. [6] MAHMOUD A M A, HUSSEIN M M, MONEER M M. Outcome and surgical strategy in critical sites in cases of psuedomyxoma peritonei[J]. J Egypt Natl Canc Inst, 2016, 28(4):249-255. [7] GUO A T, SONG X, WEI L X, et al. Histological origin of pseudomyxoma peritonei in Chinese women: clinicopathology and immunohistochemistry[J]. World J Gastroenterol, 2011, 17(30):3531-3537. [8] 王鑫鑫, 顾青峰, 张伟, 等. 腹腔镜腹腔热灌注化疗治疗腹膜假性黏液瘤[J]. 中华腔镜外科杂志:电子版, 2014(2):121-124. [9] LORD A C, SHIHAB O, CHANDRAKUMARAN K, et al. Recurrence and outcome after complete tumour removal and hyperthermic intraperitoneal chemotherapy in 512 patients with pseudomyxoma peritonei from perforated appendiceal mucinous tumours[J]. Eur J Surg Oncol, 2015, 41(3):396-399. [10] SMEENK R M, VAN VELTHUTSEN M L F, VERWAAL V J, et al. Appendiceal neoplasms and pseudomyxoma peritonei: a population based study[J]. Eur J Surg Oncol, 2008, 34(2):196-201. [11] 韩松, 李雪伟, 赵鹏翔, 等. 阑尾低级别黏液性肿瘤临床诊治的研究进展[J]. 中华解剖与临床杂志, 2019, 24(5):512-515. [12] KIM G, CHANDRAKUMARAN K, CARR N J, et al. Single centre guidelines for radiological follow-up based on 775 patients treated by cytoreductive surgery and HIPEC for appendiceal pseudomyxoma peritonei[J]. Eur J Surg Oncol, 2018, 44(9):1371-1377. |